The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S ...
The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the ...
The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza ...
The Food and Drug Administration abruptly canceled a critical meeting of the Vaccines and Related Biological Products ...
The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest ...
The federal agency, which is now overseen by a vaccine skeptic, did not offer a reason for the cancellation. It was slated to review upcoming flu vaccine formulas.
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
A meeting of FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) that selects strains to include in ...
Aptitude Medical Systems, Inc. (Aptitude) 宣布,其下一代分子 Metrix® COVID/Flu 多重检测已获得美国食品药品监督管理局 (FDA) 的紧急使用授权 ...
VRBPAC members were alerted that the meeting was canceled in an email from the FDA that did not include an explanation, ...